A randomised controlled trial of different approaches to universal antenatal Human Immunodeficiency Virus (HIV) testing: acceptability, costs and benefits

ISRCTN ISRCTN40371436
DOI https://doi.org/10.1186/ISRCTN40371436
Secondary identifying numbers HTA 93/24/11
Submission date
25/04/2003
Registration date
25/04/2003
Last edited
08/11/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Frank Johnstone
Scientific

Dept of Obstetrics and Gynaecology
University of Edinburgh
37 Chalmers Street
Edinburgh
EH3 9EW
United Kingdom

Phone +44 (0)131 229 2575 x2315
Email fdj@srv1.med.ed.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific titleA randomised controlled trial of different approaches to universal antenatal Human Immunodeficiency Virus (HIV) testing: acceptability, costs and benefits
Study objectivesWith increasing optimism about the benefits of antenatal HIV testing, particularly in terms of measures that greatly reduce the risk of infection to the baby, there is a demand for effective, acceptable testing programmes and appropriate patient information. This randomised controlled trial (RCT) was designed to compare different ways of offering testing to all pregnant women, with the aim of acquiring information about what predicts uptake and how women respond to the offer of testing, in order to define the optimal approach.
Ethics approval(s)Not provided at time of registration.
Health condition(s) or problem(s) studiedInfection and infestations: HIV/Acquired Immunodeficiency Syndrome (AIDS); Pregnancy and childbirth: Pregnancy
InterventionThe setting was a hospital antenatal clinic covering the majority of the population of Edinburgh City. The target group was all pregnant women booking at the clinic over 10 months. The design was an RCT involving four combinations of written and verbal communication, followed by the direct offer of an HIV test with written consent required for testing.
Women were sent either a specific leaflet about HIV testing in pregnancy or a leaflet containing information about HIV testing amongst information on the other antenatal blood tests. At the clinic, a core group of ten trained midwives offered the test, following either minimal or comprehensive pre-test discussion protocols printed on cards. The control group received no information and no direct offer of a test, although testing was available on request (the pre-trial situation).
Intervention typeOther
Primary outcome measureThe main outcome measures were uptake of HIV testing, knowledge of HIV and other antenatal tests, satisfaction with the consultation, anxiety, attitudes towards pregnancy and perceived benefits of testing. Opinions about testing during pregnancy were also sought using both quantitative and qualitative measures. Midwives' knowledge and attitudes were assessed to investigate their effect on women's uptake of testing.
Secondary outcome measuresNot provided at time of registration.
Overall study start date01/04/1995
Completion date31/07/1998

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants3024
Key inclusion criteriaParticipants were 3024 pregnant women, of whom 2704 (89%) completed a questionnaire which determined acceptability of testing, at their booking appointment. A sub-sample of the participants (n = 788) also completed a questionnaire at their 32-week appointment.
Key exclusion criteriaNot provided at time of registration.
Date of first enrolment01/04/1995
Date of final enrolment31/07/1998

Locations

Countries of recruitment

  • Scotland
  • United Kingdom

Study participating centre

Dept of Obstetrics and Gynaecology
Edinburgh
EH3 9EW
United Kingdom

Sponsor information

Department of Health (UK)
Government

Quarry House
Quarry Hill
Leeds
LS2 7UE
United Kingdom

Phone +44 (0)1132 545 843
Email Sheila.Greener@doh.gsi.gov.uk
Website http://www.dh.gov.uk/en/index.htm
ROR logo "ROR" https://ror.org/03sbpja79

Funders

Funder type

Government

NIHR Health Technology Assessment Programme - HTA (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article HTA monograph 01/04/1999 Yes No

Editorial Notes

08/11/2022: Internal review.